Adfrar 40 mg PFS Injection 0.4 ml Substitute
RXCipla Ltd
₹18000
(₹14760.0 per unit)
RXAlkem Laboratories Ltd
₹9374
(₹19216.75/ 1ml)
RXIpca Laboratories Ltd
₹25000
(₹25625.0/ 1ml)
RXHetero Drugs Ltd
₹25781
(₹26425.5/ 1ml)
RXTricept Life Sciences Pvt Ltd
₹26000
(₹26650.0/ 1ml)
RXRPG Life Sciences Ltd
₹28351.5
(₹29060.25/ 1ml)
RXCONCORD DRUGS LTD
₹32220
(₹40275.0/ 1ml)
RXSun Pharmaceutical Industries Ltd
₹23437.5
(₹48047.0/ 1ml)
RXAbbott India Ltd
₹21825
(₹54562.5/ 1ml)

Patients may explore substitutes in the following scenarios:
Before you switch from Adfrar 40 mg PFS Injection 0.4 ml to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - ADALIMUMAB-40MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Adfrar 40 mg PFS Injection 0.4 ml is used in the treatment of autoimmune inflammatory diseases. The detailed uses of Adfrar 40 mg PFS Injection 0.4 ml are as follows:
Adfrar 40 mg PFS Injection 0.4 ml consists of Adalimumab, which belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.
The substitutes of Adfrar 40 mg PFS Injection 0.4 ml contain the same active salt(s) - ADALIMUMAB-40MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Adfrar 40 mg PFS Injection 0.4 ml is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Adfrar 40 mg PFS Injection 0.4 ml are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Adfrar 40 mg PFS Injection 0.4 ml meet the same safety and efficacy standards as Adfrar 40 mg PFS Injection 0.4 ml, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Adfrar 40 mg PFS Injection 0.4 ml may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Adfrar 40 mg PFS Injection 0.4 ml if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Adfrar 40 mg PFS Injection 0.4 ml for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Adfrar 40 mg PFS Injection 0.4 ml is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Adfrar 40 mg PFS Injection 0.4 ml to its substitute. Always consult your doctor before switching.
Adfrar 40 mg PFS Injection 0.4 ml is used to treat Rheumatoid arthritis, Ankylosing spondylitis, Psoriatic arthritis, Plaque psoriasis, Crohn’s disease, Uveitis and Ulcerative colitis.
Adfrar 40 mg PFS Injection 0.4 ml contains Adalimumab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive.
Adfrar 40 mg PFS Injection 0.4 ml affects your immune system and makes you more susceptible to infections. Hence, it is not recommended in people with active infections like tuberculosis or abnormal liver enzymes. Adfrar 40 mg PFS Injection 0.4 ml can also increase the risk of developing cancers; hence, informing your doctor if you have a history of any cancer is essential.
Adfrar 40 mg PFS Injection 0.4 ml is an antirheumatic medicine that belongs to the TNF (tumor necrosis factor) inhibitor class. It contains the active ingredient Adalimumab.
Treatment with Adfrar 40 mg PFS Injection 0.4 ml can help reduce inflammation, pain, redness, and swelling associated with various autoimmune disorders.
Adfrar 40 mg PFS Injection 0.4 ml which contains Adalimumab, can weaken your immune system. Since it affects the immune system, it may increase your risk of developing infections. It is important to follow your doctor's advice and inform them if you have any existing infections or health concerns before starting treatment.
Adfrar 40 mg PFS Injection 0.4 ml can be used alongside other arthritis medicines such as methotrexate, prednisolone, naproxen, ibuprofen, and paracetamol. However, Adfrar 40 mg PFS Injection 0.4 ml should not be used with other biological disease-modifying antirheumatic drugs (bDMARDs).
Adfrar 40 mg PFS Injection 0.4 ml should be stopped before surgery. It can be resumed after the operation, once the wound has healed and there is no infection, as determined by your surgeon and rheumatologist.
Adfrar 40 mg PFS Injection 0.4 ml causes side effects such as rash, headache, sinusitis, upper respiratory infections, fever, and application site reactions. Therefore, please contact a doctor if these do not reduce and persist for longer durations.